In a recent study, a composite diagnostic panel of three biomarkers: L-Ficolin, hyaluronic acid (HA), and VCAM-1, was reported to detect patients at high risk of SOS as early as the first day after HCT, even before clinical manifestation of SOS (82). Here, VCAM1 is linked to spondylo-ocular syndrome.